BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 21073843)

  • 1. Anti-apoptotic and growth-promoting markers in adult medulloblastomas.
    Ongürü O; Karslioglu Y; Ozcan A; Celik E
    Clin Neuropathol; 2010; 29(6):384-9. PubMed ID: 21073843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrence in medulloblastoma - influence of clinical, histological and immunohistochemical factors.
    Srikantha U; Balasubramaniam A; Santosh V; Somanna S; Bhagavatula ID; Ashwathnarayana CB
    Br J Neurosurg; 2010 Jun; 24(3):280-8. PubMed ID: 20465457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bcl-2 expression inversely correlates with tumour cell differentiation in medulloblastoma.
    Schüller U; Schober F; Kretzschmar HA; Herms J
    Neuropathol Appl Neurobiol; 2004 Oct; 30(5):513-21. PubMed ID: 15488027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative study of classical vs. desmoplastic medulloblastomas.
    Pramanik P; Sharma MC; Mukhopadhyay P; Singh VP; Sarkar C
    Neurol India; 2003 Mar; 51(1):27-34. PubMed ID: 12865511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunohistochemical study of neoplasm-associated proteins in cerebellum medulloblastomas].
    Korshunov AG; Sycheva RV; Golanov AV
    Arkh Patol; 1998; 60(4):8-14. PubMed ID: 9791689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are childhood and adult medulloblastomas different? A comparative study of clinicopathological features, proliferation index and apoptotic index.
    Sarkar C; Pramanik P; Karak AK; Mukhopadhyay P; Sharma MC; Singh VP; Mehta VS
    J Neurooncol; 2002 Aug; 59(1):49-61. PubMed ID: 12222838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survivin expression in childhood medulloblastomas: a possible diagnostic and prognostic marker.
    Bodey B; Bodey V; Siegel SE; Kaiser HE
    In Vivo; 2004; 18(6):713-8. PubMed ID: 15646811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survivin is a negative prognostic marker in medulloblastoma.
    Pizem J; Cört A; Zadravec-Zaletel L; Popovic M
    Neuropathol Appl Neurobiol; 2005 Aug; 31(4):422-8. PubMed ID: 16008826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [An immunohistochemical study of tenascin expression in cerebellar medulloblastomas].
    Korshunov AG; Golanov AV; Sycheva RV
    Zh Vopr Neirokhir Im N N Burdenko; 1997; (4):23-7. PubMed ID: 9460893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of basic fibroblast growth factor on the differentiation, growth, and viability of a new human medulloblastoma cell line (UM-MB1).
    Kenigsberg RL; Hong Y; Yao H; Lemieux N; Michaud J; Tautu C; Théorêt Y
    Am J Pathol; 1997 Sep; 151(3):867-81. PubMed ID: 9284836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of p53/bcl-2 co-expression in patients with laryngeal squamous cell carcinoma.
    Jäckel MC; Sellmann L; Dorudian MA; Youssef S; Füzesi L
    Laryngoscope; 2000 Aug; 110(8):1339-45. PubMed ID: 10942137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of apoptosis regulatory proteins p53 and Bcl-2 in skin of patients with chronic renal failure on maintenance haemodialysis.
    El-Domyati MM; Ahmad HM; Nagy I; Zahran A
    J Eur Acad Dermatol Venereol; 2007 Jul; 21(6):795-801. PubMed ID: 17567310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apoptosis in colorectal carcinoma occurring in patients aged 45 years and under: relationship to prognosis, mitosis, and immunohistochemical demonstration of p53, c-myc and bcl-2 protein products.
    Langlois NE; Lamb J; Eremin O; Heys SD
    J Pathol; 1997 Aug; 182(4):392-7. PubMed ID: 9306959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A clinicobiological model predicting survival in medulloblastoma.
    Ray A; Ho M; Ma J; Parkes RK; Mainprize TG; Ueda S; McLaughlin J; Bouffet E; Rutka JT; Hawkins CE
    Clin Cancer Res; 2004 Nov; 10(22):7613-20. PubMed ID: 15569993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of p53 protein and the apoptotic regulatory molecules Bcl-2, Bcl-XL, and Bax in locally advanced squamous cell carcinoma of the lung.
    Shabnam MS; Srinivasan R; Wali A; Majumdar S; Joshi K; Behera D
    Lung Cancer; 2004 Aug; 45(2):181-8. PubMed ID: 15246189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical study of apoptosis-related Bcl-2 protein and its correlation with proliferation indices (Ki67, PCNA), tumor suppressor genes (p53, pRb), the oncogene c-erbB-2, sex steroid hormone receptors and other clinicopathological features, in normal, hyperplastic and neoplastic endometrium.
    Mitselou A; Ioachim E; Kitsou E; Vougiouklakis T; Zagorianakou N; Makrydimas G; Stefanaki S; Agnantis NJ
    In Vivo; 2003; 17(5):469-77. PubMed ID: 14598611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calbindin-d(28k): a marker of recurrence for medulloblastomas.
    Pelc K; Vincent S; Ruchoux MM; Kiss R; Pochet R; Sariban E; Decaestecker C; Heizmann CW
    Cancer; 2002 Jul; 95(2):410-9. PubMed ID: 12124842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatic cell transfer of c-Myc and Bcl-2 induces large-cell anaplastic medulloblastomas in mice.
    Jenkins NC; Rao G; Eberhart CG; Pedone CA; Dubuc AM; Fults DW
    J Neurooncol; 2016 Feb; 126(3):415-24. PubMed ID: 26518543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C-kit expression and mutational analysis in medulloblastoma.
    Chilton-Macneill S; Ho M; Hawkins C; Gassas A; Zielenska M; Baruchel S
    Pediatr Dev Pathol; 2004; 7(5):493-8. PubMed ID: 15547773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pediatric nasopharyngeal carcinoma: better prognosis and increased c-Kit expression as compared to adults.
    Bar-Sela G; Ben Arush MW; Sabo E; Kuten A; Minkov I; Ben-Izhak O
    Pediatr Blood Cancer; 2005 Sep; 45(3):291-7. PubMed ID: 15558705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.